Level B· Emerging clinical evidence with positive signalsClinical TrialPubMed

[Advancement of adipose-derived stem cells assisted autologous lipotransfer in breast repair and reconstruction].

Tian C., Lü Q.

Clinical Trial, published in Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2013) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Clinical Trial
Journal
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2013)
Country
China
Reported sample size
—
Source database
PubMed
PMID
24397141
Citations
1

Abstract (original English)

Objective To review the latest progress in the major biological properties of adipose-derived stem cells (ADSCs) and ADSCs assisted autologous lipotransfer in breast repair and reconstruction. Methods Recent literature about ADSCs assisted autologous lipotransfer in breast repair and reconstruction was reviewed. Results ADSCs have multipotential differentiation capacity, and they could promote angiogenesis and regulate immune reactions. ADSCs assisted autologous lipotransfer can obtain satisfactory effectiveness in breast repair and reconstruction with few complications, but more studies are needed to confirm the long-term safety. Conclusion ADSCs assisted autologous lipotransfer has good effectiveness in breast repaired and reconstruction. But further clinical trials are needed to confirm the long-term safety.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
AdipocytesAdipose TissueCell DifferentiationCells, CulturedFemaleHumansInjectionsMammaplastyPostoperative ComplicationsStem Cell Transplantation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.